Skip to content
Back to ABCL

AbCellera Biologics Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
11
Purchases
11
Sales
0
Purchase value
$3.47M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Andrew BoothChief Financial Officer
4
Filed Nov 13, 2026Period of report Nov 13, 20260001834411-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 13, 2026
Common Shares8,600$11.33$97.44K491,400Direct
Open on SEC EDGAR
Thermopylae Holdings Ltd.10% owner
4
Filed Nov 12, 2026Period of report Nov 12, 20260001834449-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 12, 2026
Common SharesF160,565$11.54$698.92K56,194,662Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $11.29 to $11.86. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Michael R HaydenDirector
4
Filed Aug 24, 2026Period of report Aug 24, 20260001628280-26-058684
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 24, 2026
Common SharesF1F253,613$10.64$570.44K1,373,397IndirectSee footnote
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.49 to $10.70. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  2. F2These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.
Open on SEC EDGAR
John S. MontalbanoDirector
4
Filed Aug 18, 2026Period of report Aug 18, 20260001834423-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 18, 2026
Common Shares10,000$11.03$110.30K251,000Direct
Open on SEC EDGAR
Andrew BoothChief Financial Officer
4
Filed Aug 14, 2026Period of report Aug 14, 20260001834411-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 14, 2026
Common Shares37,200$10.32$383.90K482,800Direct
Open on SEC EDGAR
Michael R HaydenDirector
4
Filed Aug 14, 2026Period of report Aug 12, 20260001628280-26-057007
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 12, 2026
Common SharesF1F246,387$10.37$481.03K1,319,784IndirectSee footnote
Filing footnotes · 2
  1. F1The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.25 to $10.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
  2. F2These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.
Open on SEC EDGAR
John S. MontalbanoDirector
4
Filed May 18, 2026Period of report May 14, 20260001834423-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 14, 2026
Common Shares20,000$4.77$95.40K241,000Direct
Open on SEC EDGAR
Thermopylae Holdings Ltd.10% owner
4
Filed Mar 2, 2026Period of report Feb 27, 20260001834449-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 27, 2026
Common SharesF138,000$3.44$130.72K56,134,097Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.42 to $3.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Andrew BoothChief Financial Officer
4
Filed Feb 27, 2026Period of report Feb 27, 20260001834411-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 27, 2026
Common Shares42,600$3.42$145.69K195,600Direct
Open on SEC EDGAR
Thermopylae Holdings Ltd.10% owner
4
Filed Feb 27, 2026Period of report Feb 26, 20260001834449-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseFeb 26, 2026
Common SharesF1177,457$3.27$580.28K56,096,097Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.19 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
John S. MontalbanoDirector
4
Filed Nov 26, 2025Period of report Nov 26, 20250001834423-25-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 26, 2025
Common Shares50,000$3.5692$178.46K221,000Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.